Harvest Time? Medicago And GSK Expect Summer Readout For Plant-Based COVID Vaccine
Vaccine Grown In Greenhouse Crops
Executive Summary
Medicago’s vaccine has generated a strong immune responses in a Phase II trial, which could see it finally reap the benefits of its plant-based technology.
You may also be interested in...
Medicago Shut Down: COVID-19 Vaccine Competition Among Reasons
While the close-down schedule for the Canadian vaccine technology specialist is still unclear, all ongoing R&D projects at the firm will be terminated, Japanese parent group tells Scrip.
GSK/Medicago COVID-19 Vaccine Looks Like Also-Ran But Antibody Shows Value Against Omicron
GSK looks unlikely to be a major player in COVID-19 vaccines, even in boosters, but its partnership with Vir could pay off handsomely.
Philip Morris Rebuts 'Cynical' Claims About £1bn Vectura Buy
Buying the UK inhalation specialist Vectura will be key to the transformation of Philip Morris International as it looks to reduce its reliance on smoking products, CEO Jacek Olczak has declared.